当前位置:首页 - 行情中心 - 仙琚制药(002332) - 财务分析 - 现金流量表

仙琚制药

(002332)

  

流通市值:96.49亿  总市值:96.94亿
流通股本:9.85亿   总股本:9.89亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,696,576,041.96758,022,233.963,465,941,898.042,593,688,758.7
  收到的税费返还4,285,265.74,155,449.96-1,290,191.47
  收到其他与经营活动有关的现金49,004,951.1347,248,603.97173,434,196.581,039,492.56
  经营活动现金流入小计1,749,866,258.79809,426,287.893,639,376,094.542,676,018,442.73
  购买商品、接受劳务支付的现金372,594,898.48193,868,509.571,133,796,704.77859,717,627.93
  支付给职工以及为职工支付的现金401,830,500.55193,980,403.96730,928,558.28535,024,414.76
  支付的各项税费167,749,08979,196,674.94254,063,557.57196,144,183.39
  支付其他与经营活动有关的现金808,021,756.31323,958,967.41,121,931,898.53867,706,138.81
  经营活动现金流出小计1,750,196,244.34791,004,555.873,240,720,719.152,458,592,364.89
  经营活动产生的现金流量净额-329,985.5518,421,732.02398,655,375.39217,426,077.84
二、投资活动产生的现金流量:
  收回投资收到的现金--16,000,00016,000,000
  取得投资收益收到的现金--4,205,0002,205,000
  处置固定资产、无形资产和其他长期资产收回的现金净额23,662.666,405.3447,260,213.4449,572,522.76
  投资活动现金流入小计23,662.666,405.3467,465,213.4467,777,522.76
  购建固定资产、无形资产和其他长期资产支付的现金136,330,874.2769,740,347.25207,586,758.86169,452,623.38
  投资支付的现金290,909-40,300,00040,300,000
  投资活动现金流出小计136,621,783.2769,740,347.25247,886,758.86209,752,623.38
  投资活动产生的现金流量净额-136,598,120.61-69,733,941.91-180,421,545.42-141,975,100.62
三、筹资活动产生的现金流量:
  吸收投资收到的现金900,000900,000--
  其中:子公司吸收少数股东投资收到的现金900,000900,000--
  取得借款收到的现金321,500,0009,306,279.635,618,396.295,000,000
  收到其他与筹资活动有关的现金6,533,205.13-3,450,890.5-
  筹资活动现金流入小计328,933,205.1310,206,279.639,069,286.795,000,000
  偿还债务支付的现金6,385,092.814,925,553.7169,530,998.18113,355,787.25
  分配股利、利润或偿付利息支付的现金300,127,420.42148,326.07300,191,071.46299,397,848.07
  其中:子公司支付给少数股东的股利、利润2,000,000-2,000,0001,966,300
  支付其他与筹资活动有关的现金3,308,865.81-5,172,073.017,254,168.88
  筹资活动现金流出小计309,821,379.045,073,879.77474,894,142.65420,007,804.2
  筹资活动产生的现金流量净额19,111,826.095,132,399.86-465,824,855.86-415,007,804.2
四、汇率变动对现金及现金等价物的影响42,751,638.3824,611,399.83-6,127,786.58-965,194.56
五、现金及现金等价物净增加额-75,064,641.69-21,568,410.2-253,718,812.47-340,522,021.54
  加:期初现金及现金等价物余额1,376,132,147.751,376,132,147.751,629,850,960.221,629,850,960.22
  期末现金及现金等价物余额1,301,067,506.061,354,563,737.551,376,132,147.751,289,328,938.68
补充资料:
  净利润296,096,657.34-399,923,214.68-
  资产减值准备29,152,050.72-54,955,757.75-
  固定资产和投资性房地产折旧104,519,024.44-201,413,905.58-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧104,519,024.44-201,413,905.58-
  无形资产摊销10,609,292.26-18,896,169.57-
  长期待摊费用摊销1,464,705.57-1,925,043.04-
  处置固定资产、无形资产和其他长期资产的损失-46,212,235.3--283,085.44-
  固定资产报废损失888,061.12-1,314,141.84-
  财务费用3,724,010.57--7,442,068.23-
  投资损失9,438,418.86-8,080,022.4-
  递延所得税-3,512,637.94--7,141,088.95-
  其中:递延所得税资产减少-3,512,637.94--7,141,088.95-
  存货的减少-54,828,485.2--88,142,337.37-
  经营性应收项目的减少-152,345,545.9--280,879,215.87-
  经营性应付项目的增加-201,285,441.7-89,600,356.74-
  现金的期末余额1,301,067,506.06-1,376,132,147.75-
  减:现金的期初余额1,376,132,147.75-1,629,850,960.22-
  现金及现金等价物的净增加额-75,064,641.69--253,718,812.47-
公告日期2025-08-272025-04-242025-04-242024-10-26
审计意见(境内)标准无保留意见
TOP↑